Disease-Induced Modification in Nanoparticle-Corona Identity and Toxicity
Disease-Induced Modification in Nanoparticle-Corona Identity and Toxicity
批准号:
9056595
负责人:
Jonathan Henry Shannahan
金额:
$8.99万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-20 至 2016-12-31
关键词:
AddressAnimal ModelAreaAtherosclerosisBiodistributionBiologicalBiologyCardiovascular DiseasesCell Surface ReceptorsCell surfaceCellsCharacteristicsChronicChronic DiseaseComplexContrast MediaDataDevelopmentDextransDiseaseDrug Delivery SystemsElectron MicroscopyEndothelial CellsEnvironmentEvaluationFlow CytometryGoalsHealthHumanHyperlipidemiaIn VitroIndividualInductively Coupled Plasma Mass SpectrometryKnowledgeLipidsMagnetic Resonance ImagingMediatingMetabolic syndromeMicroscopyModificationObesityPatternPhysiologicalPopulationProductionPropertyProteinsProteomicsPublicationsReactive Oxygen SpeciesRoleSafetySerumSerum ProteinsSilverTestingTherapeuticTimeToxic effectToxicologyVariantantimicrobialcell typecellular targetingclinically relevantcytotoxicitydesignin vivoinflammatory markerinterestiron oxidemacromoleculemacrophagemetabolomicsnanofabricationnanomaterialsnanomedicinenanoparticlenanotherapeuticnanotoxicitynanotoxicologynovelreceptorresponsescreeningsurface coatinguptakevascular inflammation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nanomaterials are increasingly being utilized for biomedical applications as therapeutics and drug delivery systems. Following their introduction into a physiological environment they rapidly associate a variety of macromolecules forming a corona. This corona modifies the size and interactive interface of the nanomaterial resulting in altered bio distribution, clearance, activity, and toxicity. The composition of the corona is dependent on the physicochemical properties of the nanomaterial, as well as, the physiological environment. To date most evaluation of nanomaterial toxicity is performed under normal, healthy conditions. However, due to the vast and growing portion of our population that suffer from chronic conditions such as obesity and cardiovascular diseases these nanomaterials will not be introduced into healthy physiological environments. In this proposal we hypothesize that an underlying condition known to alter serum protein and lipid content, hyperlipidemia, will modify the corona that forms on nanomaterials as will different sizes and therapeutic surface coatings. Further we will examine how these modifications in coronal composition influence cellular uptake, in vivo bio distribution, subcellular localization, intracellular fate, and toxiciy. To test this hypothesis we will utilize iron oxide nanoparticles, which are currently in development for biomedical applications including their use as MRI contrast agents and silver nanoparticles, which are being used for their antimicrobial/fungal properties. Cellular interactions and toxicological effects will be examined in macrophages and endothelial cells to represent two key cell types that will interact with nanomaterials and are critical in inflammation and vascular biology. Ultimately, through a thorough understanding of the corona and its biological consequences gained from this proposal, we can develop effective nanotherapeutics with limited toxicological implications.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.tiv.2018.05.003
发表时间:
2018-09
期刊:
Toxicology in vitro : an international journal published in association with BIBRA
影响因子:
--
作者:
[Adamson SX, Lin Z, Chen R, Kobos L, Shannahan J]
通讯作者:
Shannahan J
Altered formation of the iron oxide nanoparticle-biocorona due to individual variability and exercise.
由于个体差异和运动,氧化铁纳米颗粒生物冠的形成发生了改变。
DOI:
10.1016/j.etap.2018.07.014
发表时间:
2018
期刊:
Environmental toxicology and pharmacology
影响因子:
4.3
作者:
[Kobos,LisaM, Adamson,SherleenXue-Fu, Evans,Sheelagh, Gavin,TimothyP, Shannahan,JonathanH]
通讯作者:
Shannahan,JonathanH
DOI:
10.1515/ntrev-2016-0098
发表时间:
2017-08
期刊:
Nanotechnology reviews
影响因子:
7.4
作者:
[Shannahan J]
通讯作者:
Shannahan J
Early Periodontal Health Impacts of Electronic Nicotine Delivery System (ENDS) Usage
-
批准号:10691174
-
项目类别:
-
资助金额:$62.4万
-
财政年份:2022
-
负责人:Jonathan Henry Shannahan
-
依托单位:
Compromised Resolution of Inflammation following Nanoparticle Exposure in Metabolic Syndrome
-
批准号:10597165
-
项目类别:
-
资助金额:$33.77万
-
财政年份:2022
-
负责人:Jonathan Henry Shannahan
-
依托单位:
Compromised Resolution of Inflammation following Nanoparticle Exposure in Metabolic Syndrome
-
批准号:10441741
-
项目类别:
-
资助金额:$33.77万
-
财政年份:2022
-
负责人:Jonathan Henry Shannahan
-
依托单位:
African-American Susceptibility to Periodontal Disease due to Electronic Nicotine Delivery Systems (ENDS) Usage
-
批准号:10453478
-
项目类别:
-
资助金额:$8.35万
-
财政年份:2021
-
负责人:Jonathan Henry Shannahan
-
依托单位:
African-American Susceptibility to Periodontal Disease due to Electronic Nicotine Delivery Systems (ENDS) Usage
-
批准号:10561750
-
项目类别:
-
资助金额:$27.03万
-
财政年份:2021
-
负责人:Jonathan Henry Shannahan
-
依托单位:
Assessment of Cured-In-Place Pipe Installation Emissions and Toxicity
-
批准号:9808278
-
项目类别:
-
资助金额:$7.47万
-
财政年份:2019
-
负责人:Jonathan Henry Shannahan
-
依托单位:
Disease-Induced Modification in Nanoparticle-Corona Identity and Toxicity
-
批准号:9392983
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2017
-
负责人:Jonathan Henry Shannahan
-
依托单位:
海外基金